| Bickler, Philip E |
| Completed | N/A | 13 | US | Pulse oximeter | Nihon Kohden, University of California, San Francisco | Hypoxia | 05/21 | 02/22 | | |
NCT05745675: Accuracy of Pulse Oximeters With Profound Hypoxia At Rest (NIHO16) |
|
|
| Completed | N/A | 11 | US | Pulse oximeter | Nihon Kohden, University of California, San Francisco | Hypoxia | 01/23 | 04/24 | | |
NCT05745662: Accuracy of Pulse Oximeters With Profound Hypoxia At Rest (NIHO17) |
|
|
| Completed | N/A | 11 | US | Pulse Oximeter | Nihon Kohden, University of California, San Francisco | Hypoxia | 02/23 | 04/24 | | |
| Completed | N/A | 12 | US | Mixtures of nitrogen, air, and carbon dioxide, Radial arterial cannula | Gabi SmartCare | Hypoxia | 03/23 | 03/23 | | |
NCT06149416: SpO2 Accuracy of Noninvasive Pulse Oximeter Sensor With Motion Conditions |
|
|
| Completed | N/A | 11 | US | Experimental Masimo RD SET SpO2 Adhesive Sensors | Stryker Sustainability Solutions | Healthy, Hypoxia | 05/23 | 05/23 | | |
NCT06634693: Controlled Desaturation Study for TipTraQ SpO2 Performance Validation |
|
|
| Completed | N/A | 12 | US | | PranaQ Pte. Ltd. | Hypoxia | 10/23 | 10/23 | | |
NCT06101654: Accuracy of Evie Ring Pulse Oximeter in Profound Hypoxia |
|
|
| Completed | N/A | 11 | US | Pulse oximeter | Movano Health, University of California, San Francisco | Hypoxia | 01/24 | 01/24 | | |
NCT05807464: Accuracy of Pulse Oximeters With Profound Hypoxia At Rest (NIHO18) |
|
|
| Completed | N/A | 12 | US | Pulse Oximeter | Nihon Kohden, University of California, San Francisco | Hypoxia | 04/23 | 05/24 | | |
NCT05807477: Accuracy of Pulse Oximeters With Profound Hypoxia At Rest (NIHO19) |
|
|
| Completed | N/A | 12 | US | Pulse Oximeter | Nihon Kohden, University of California, San Francisco | Hypoxia | 04/23 | 05/24 | | |
NCT06459206: Accuracy of the EvieMED Ring Pulse Oximeter in Profound Hypoxia |
|
|
| Recruiting | N/A | 12 | US | Pulse oximeter | Movano Health, University of California, San Francisco | Hypoxia | 06/24 | 06/24 | | |
| McCluggage, Julie |
NCT03907852: Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer |
|
|
| Active, not recruiting | 1/2 | 36 | Canada, US | gavo-cel, fludarabine, cyclophosphamide, Nivolumab, Ipilimumab | TCR2 Therapeutics, Bristol-Myers Squibb | Mesothelioma, Mesothelioma, Malignant, Mesothelioma; Pleura, Mesotheliomas Pleural, Mesothelioma Peritoneum, Cholangiocarcinoma, Cholangiocarcinoma Recurrent, Ovarian Cancer, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, High Grade Ovarian Serous Adenocarcinoma | 11/28 | 11/28 | | |
| Bokoch, Michael P |
| Recruiting | 2/3 | 50 | US | Angiotensin II, Giapreza (synthetic human angiotensin II), Saline, 0.9% normal saline | University of California, San Francisco, La Jolla Pharmaceutical Company | Liver Transplant; Complications, Vasoplegia | 09/25 | 09/26 | | |
| Kangiszer, Gyula |
KEYNOTE F73, NCT05369000: Trial of LAVA-1207 in Patients with Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer |
|
|
| Active, not recruiting | 1/2 | 180 | Europe, US | LAVA-1207, LAVA-1207 plus Pembrolizumab | Lava Therapeutics, Merck Sharp & Dohme LLC | Metastatic Castration Resistant Prostate Cancer | 04/27 | 04/27 | | |
